Fierce Pharma November 14, 2022
Sponsored by Cognizant

At first, the metaverse might seem to represent way too much uncertainty for life sciences organizations. After all, this virtual world it still evolving. The promise of the metaverse is an interoperable, persistent space within which people can virtually travel, interact and perform a wide variety of tasks, all with a single identity.

In reality, the metaverse has yet to deliver on that promise. Currently, it’s a disparate set of platforms, applications and games, with each experience walled off from the next. What unites the metaverse today is a common set of technological building blocks that underpin these different experiences: augmented reality (AR), virtual reality (VR), blockchain and gamification, among others. (See our eBook “A pragmatist’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Metaverse/VR, Pharma / Biotech, Technology
Cullinan Nets $280M Investment and Targets CD19 in Lupus
Eli Lilly Shows Obesity Drug Zepbound Can Treat Sleep Apnea Too
Fierce Biotech Layoff Tracker 2024: Ultimovacs says goodbye to 40% of staff; Major pharmas turn to layoffs
Lilly's Prevail walks away from Precision gene editing collab
Eli Lilly's tirzepatide scores again, this time in 2 sleep apnea trials

Share This Article